Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
Bioorganic & Medicinal Chemistry Letters|August 6, 2002
A 5-fluorodeoxyuridine prodrug as targeted therapy for prostate cancerAnnastasiah Mhaka, Sam R Denmeade, Wei Yao, et al.
Molecular Cancer Therapeutics|November 21, 2007
A prostate-specific antigen activated N-(2-hydroxypropyl) methacrylamide copolymer prodrug as dual-targeted therapy for prostate cancerSachin S Chandran, Anjan Nan, D Marc Rosen, et al.
The Oncologist|April 7, 2023
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate CancerSamuel R Denmeade, Laura A Sena, Hao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancersYi Xu, Susan L Dalrymple, Robyn E Becker, et al.
Journal of Medicinal Chemistry|May 23, 2013
Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitorsMaya B Kostova, D Marc Rosen, Ying Chen, et al.
The Journal of Urology|June 7, 2000
Complete androgen blockade for prostate cancer: what went wrong?M Laufer, S R Denmeade, V J Sinibaldi, et al.
Oncotarget|June 2, 2018
PSA-selective activation of cytotoxic human serine proteases within the tumor microenvironment as a therapeutic strategy to target prostate cancerOliver C Rogers, Lizamma Anthony, D Marc Rosen, et al.
The Prostate|February 3, 2016
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategyEmmanuel S Akinboye, W Nathaniel Brennen, D Marc Rosen, et al.
The Prostate|May 7, 2019
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU-AA-302Benjamin A Teply, Fang Qiu, Emmanuel S Antonarakis, et al.
Journal of Clinical Psychology|May 14, 2024
Narcissistic personality disorder in the ICD-11: Severity and trait profiles of grandiosity and vulnerabilityNicholas J S Day, Ava Green, Georgia Denmeade, et al.
Pageof 23